Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
Deloitte
Citi
Baxter
Chinese Patent Office
Covington
Argus Health
Accenture
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

MIRALAX Drug Profile

« Back to Dashboard

When do Miralax patents expire, and when can generic versions of Miralax launch?

Miralax is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in MIRALAX is polyethylene glycol 3350. There are four hundred and seventeen drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350 profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare LlcMIRALAXpolyethylene glycol 3350FOR SOLUTION;ORAL022015-001Oct 6, 2006OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
McKinsey
Federal Trade Commission
Harvard Business School
Cipla
Mallinckrodt
US Department of Justice
Novartis
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot